Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease

Aliment Pharmacol Ther. 2019 Feb;49(4):476-477. doi: 10.1111/apt.15104.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human
  • Humans
  • Inflammatory Bowel Diseases*